These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1950339)

  • 21. Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection.
    Sughrue ME; Chang EF; Tyrell JB; Kunwar S; Wilson CB; Blevins LS
    Pituitary; 2009; 12(3):158-64. PubMed ID: 18651225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
    Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL
    Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
    Rasmussen C; Bergh T; Nillius SJ; Wide L
    Fertil Steril; 1985 Jul; 44(1):31-4. PubMed ID: 4007192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the therapeutic results of bromocriptine treatment of prolactin microadenoma and macroadenoma].
    Jin ZM; Shi YF; Chen GL
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):669-72, 702-3. PubMed ID: 2086009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
    Primeau V; Raftopoulos C; Maiter D
    Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
    Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
    Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromocriptine treatment of postoperative prolactinoma patients.
    Yang DY; Wang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):346-50. PubMed ID: 8087709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on prolactinomas. Part 2: Treatment and management strategies.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
    Sabuncu T; Arikan E; Tasan E; Hatemi H
    Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas.
    Perrin G; Treluyer C; Trouillas J; Sassolas G; Goutelle A
    Pathol Res Pract; 1991 Jun; 187(5):587-92. PubMed ID: 1923955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas.
    Huang HY; Zhai W; Tang H; Hui GZ; Wu ZB
    Endocrine; 2018 Nov; 62(2):464-469. PubMed ID: 30238326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy, delivery and lactation in hyperprolactinaemic women.
    Sas M; Godó G; Koloszár S
    Acta Med Hung; 1986; 43(1):13-22. PubMed ID: 3774415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia.
    Karunakaran S; Page RC; Wass JA
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):295-300. PubMed ID: 11298080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fertility in prolactinomas--considerations concerning some clinical cases].
    Ionescu O; Vulpoi C; Ungureanu MC; Ionescu D; Zbranca E
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):806-9. PubMed ID: 12092244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effects of pregnancy on prolactin secretion in occulted hyperprolactinemia].
    Matsuoka R; Mori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1617-22. PubMed ID: 1744458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy.
    van Roon E; van der Vijver JC; Gerretsen G; Hekster RE; Wattendorff RA
    Fertil Steril; 1981 Aug; 36(2):173-7. PubMed ID: 6790306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of prolactinomas during pregnancy.
    Witek P; Zieliński G
    Minerva Endocrinol; 2013 Dec; 38(4):351-63. PubMed ID: 24285103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.